Literature DB >> 8827455

Evidence for the existence of Ca2+/calmodulin-dependent protein kinase IV kinase isoforms in rat brain.

S Okuno1, T Kitani, H Fujisawa.   

Abstract

Calmodulin-dependent protein kinase IV (CaM-kinase IV), which plays crucial roles in the functioning of Ca2+ in the central nervous system and immune system, is markedly activated upon phosphorylation by the action of CaM-kinase IV kinase. Northern and Western blot analyses of CaM-kinase IV kinase showed relatively weak reactions in the rat cerebellum, where the activity of CaM-kinase IV kinase has been demonstrated to exist, indicating that CaM-kinase IV kinase isoforms distinct from the enzyme cloned from the cerebral cortex may exist in the cerebellum. When the crude extracts of rat cerebral cortex, brain stem, and cerebellum were immunotitrated with antibody against the cloned enzyme, only approximately 46, 56, and 25% of the enzyme activity of the respective extracts were immunoprecipitated. Thus, at least two distinct isoforms of CaM-kinase IV kinase appear to exist in the brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827455     DOI: 10.1093/oxfordjournals.jbchem.a021365

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  2 in total

1.  Structural Analysis of Inhibitor Binding to CAMKK1 Identifies Features Necessary for Design of Specific Inhibitors.

Authors:  André da Silva Santiago; Rafael M Couñago; Priscila Zonzini Ramos; Paulo H C Godoi; Katlin B Massirer; Opher Gileadi; Jonathan M Elkins
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

2.  Binding and structural analyses of potent inhibitors of the human Ca2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors.

Authors:  Gerson S Profeta; Caio V Dos Reis; André da S Santiago; Paulo H C Godoi; Angela M Fala; Carrow I Wells; Roger Sartori; Anita P T Salmazo; Priscila Z Ramos; Katlin B Massirer; Jonathan M Elkins; David H Drewry; Opher Gileadi; Rafael M Couñago
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.